You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Clinical Trial Search Results

Baystate has clinical trials in several medical specialties. Clinical trials can help our patients by making advanced care available to them right in their communities.

Is volunteering for a clinical trial right for you? Learn more.

Page 1 of 1 | Results 1 - 9 of 9

A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity

Diabetes, Obesity, Pediatrics

Baystate Children’s Specialty Center, 50 Wason Avenue, Springfield, MA

Recruiting

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Cancer, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Cancer - Pediatric, Cancer, Cancer - Leukemia

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Cancer - Leukemia, Cancer, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Improving Outcome in Neonatal Abstinence Syndrome: a study to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb

To compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age.

Pediatrics

Baystate Children's Hospital, 759 Chestnut Street, Springfield, MA 01199

Active

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

PROTECT Study in Children and Adolescents with Newly Diagnosed Type 1 Diabetes (T1D)

Diabetes, Pediatrics

Baystate Children’s Specialty Center, 50 Wason Avenue, Springfield, MA

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Cancer - Leukemia, Cancer - Pediatric, Cancer, Genetics

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Cancer, Cancer - Lymphoma, Cancer - Pediatric

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active
Page 1 of 1 | Results 1 - 9 of 9